Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: A meta-analysis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 38

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Oct 14, 2014; 20(38): 14051-14057
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.14051

Full Size Figure Download Figure

Figure 3 Forest plot of overall model for end-stage liver disease scores during follow up.

Citation: Pan XN, Zheng LQ, Lai XH. Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: A meta-analysis. World J Gastroenterol 2014; 20(38): 14051-14057
URL: https://www.wjgnet.com/1007-9327/full/v20/i38/14051.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i38.14051

Pan XN, Zheng LQ, Lai XH. Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: A meta-analysis. World J Gastroenterol 2014; 20(38): 14051-14057 [PMID: 25320545 DOI: 10.3748/wjg.v20.i38.14051]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.